Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rose who wrote (3125)	3/17/2001 1:55:29 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 52153

Robert: >> the biotechs in aggregate have performed far better than most new econ sectors << Falicy, based on a few companies and the concept that BTK represents biotech. Or, if you liked, based on the constant patter on CNBC. Intel got clobbered, correct? Off 63% from its 52 week high? Everyone says that biotech had to catch up with tech? That's nothing. Take a look at the two year charts........... quote.yahoo.com quote.yahoo.com (73% off of 52 week high) quote.yahoo.com quote.yahoo.com quote.yahoo.com quote.yahoo.com (an outstanding performer, and only off 60%!) Pick your biotech, apart from a few stocks that compose the "biotech" of CNBC. Sorry, but your logic infuriates me. It's the trap of Arnhold Barfholder et al., their "Siren". It's the logic wielded by those who don't know the individual stocks -- and their inherent value -- to control the sector. Rick